We’re in the game and we’re just getting started!
We look at the exciting programs currently in progress and what is to come in 2022 and beyond.
“
It was great….You are moving fast which is good……I like that you are spread out in a few lanes, and they can all work…..It is interesting for me to see how you have become an investment professional in one of the toughest spaces
RalphLong-time Wall Street Exec & Successful Early-Stage Tech Investor
“
I just wanted to say that your investor day was great. I really like your early introduction about what you have learned when you established Bellicum.
Oren
Jump to chapters using the playbar icons or view the list of all chapters using the chapters list icon located in the bottom right of the video.
INVESTOR DAY AGENDA
Introductory Remarks
0:00:00 – 0:01:38
History of Rapha Capital Management
0:01:38 – 0:24:53
Bellicum Pharmaceuticals
0:02:43 – 0:19:58
Rapha Capital Management
0:20:00 – 0:22:28
Summary of Rapha Capital Investment (“RCI”) I - XIII with several highlighted companies
0:22:29 – 0:28:11
AsclepiX Therapeutics, Inc.https://asclepix.com - Click here to view website
0:28:23 – 0:34:15
FIZE Medical, Inc.https://fizemedical.com - Click here to view website
0:34:18 – 0:41:08
Imagin Medical, Inc.https://imaginmedical.com - Click here to view website
0:41:09 – 0:43:25
New Company Formation
0:43:32 – 0:48:13
PONCE Therapeutics – anti-aging of skin and other organs https://poncetherapeutics.com - Click here to view website
0:48:13 – 1:07:41
DELIVER Therapeutics – high throughput screening for novel oncology drugs https://delivertherapeutics.com - Click here to view website
1:07:41 – 1:31:36
**BREAK**
1:31:36 – 1:45:03
K2 Biolabs - Foundation and Leadership
1:45:03 – 1:56:05
VC Fund Launch - Rapha Capital BioVentures Fund I Currently open to new investors - Click here to register
1:56:05 – 2:06:32
SPAC IPO - Arbor Rapha Capital Bioholdings Corp. I Currently open to new investors - Click here to learn more
2:06:32 – 2:17:41
**SUMMARY**
2:17:41 – 2:19:30
Previous PostArbor Rapha Capital Bioholdings Corp. I Announces the Separate Trading of its Shares of Class A Common Stock and Redeemable Warrants Commencing December 20, 2021
Next PostRapha Capital BioVentures Fund I Launches DELIVER Therapeutics Inc. with $3 Million Convertible Note Financing
or view the list of all chapters using the chapters list icon 
located in the bottom right of the video.
